FDA issues psychedelic therapy guidance as Clearmind notes federal push
Go back to FDA issues psychedelic therapy guidance as Clearmind notes federal push| (NASDAQ: CMND) | Delayed: 1.03 -0.13 (11.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.16 | 52 Week High | $ | |||
| Open | $1.15 | 52 Week Low | $ | |||
| Day High | $1.15 | P/E | N/A | |||
| Day Low | $0.92 | EPS | $ | |||
| Volume | 3,066,194 | |||||
